Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Absorption Systems LP
Absorption Systems and ChanTest Collaborate to Add Ion Channel Interaction Studies to the Absorption Systems Safety Suite™
April 24th, 2009
Absorption Systems LP, the authority on drug absorption, and ChanTest, the leading experts in ion channels, GPCRs (G-protein coupled receptors) and in vitro cardiac risk assessment, announced they will collaborate to expand Absorption Systems’ suite of drug metabolism studies to provide data on the impact that a therapy may have on the heart. Absorption Systems’ pharmaceutical and biotechnology industry customers that work with the company to secure in vitro drug metabolism data for FDA submissions can now request studies that use ChanTest’s extensive library of cell lines for assessing a drug’s impact on cardiac tissue. The ChanTest assays will be available through the Absorption Systems...
Source: Health Business Week (2009-04-24)
|
|
Advertisement |
|
|
|
